Merck & Co. Inc. buy Guggenheim
Start price
11.04.23
/
50%
€103.40
Target price
11.04.24
€113.61
Performance (%)
13.73%
End price
12.04.24
€117.60
Summary
This prediction ended on 12.04.24 with a price of €117.60. The prediction had a final performance of 13.73%. Guggenheim has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.77 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 0.963% | 0.963% | 20.321% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Guggenheim from $123.00 to $124.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€68.70
17.04.25
17.04.25
€101.20
17.04.26
17.04.26
52.55%
27.02.26
27.02.26
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.60
06.02.26
06.02.26
€118.75
06.02.27
06.02.27
1.16%
27.02.26
27.02.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.40
12.02.25
12.02.25
€110.77
12.02.26
12.02.26
20.14%
13.02.26
13.02.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-21.04%
07.11.25
07.11.25